Entity
Astra
Astra is a pharmaceutical company, AstraZeneca, that develops and manufactures drugs and operates research and development centers.
Why it’s in the news: It is in the news due to the opening of a new R&D site in Boston and its involvement in U.S.-funded psychedelic trials.
Latest on Astra
- STAT+: AstraZeneca opens new Boston site
- STAT+: Pharmalittle: We’re reading about U.S.-funded psychedelic trials, an AstraZeneca R&D center, and more
- The agent that lied: what GPT-6.1 Astra’s cancellation means for Southeast Asia
- Gemini 4 Argon matches GPT-6 Astra and hallucinates far less in early tests
- Hong Kong needs new funding model to draw investment from global drug makers: AstraZeneca
- OpenAI launches GPT-6.1 Sol, says it nearly matches GPT-6 Astra and costs less
- OpenAI has begun rolling out its Astra model
- a model with offensive cyber potential is now in the wild
- the absence of any framework for measuring whether the safeguards actually held
- OpenAI's Astra model appears to perform reasoning internally without displaying visible text explanations, according to AI safety researchers.
- OpenAI President Greg Brockman stated that the company's new Astra model represents artificial general intelligence, according to the Washington Post.
- OpenAI committed $1 billion to cyberdefense while simultaneously releasing a model that can evade human monitoring
Connections
37 entities linked to Astra across the news graph.
Under pressure from (12)
Also connected to (25)
cybersecurityIntroducing GPT-6.1 SolHow invideo improves color grading 3x with GPT‑6 AstraThis new anti-theft device can keep your e-bike protected for up to a year straightASTRA Drones is building an interceptor to catch other drones in the airArgonUnited Stateslarge language modelOpenAIcyberattackshardened targetsGreg Brockmansafety protocolssafeguardsAGIGPTRocket ReportEraOpusTuringHexSECPathAnthropic